» Articles » PMID: 33994783

Incidence and Prognostic Factors of Respiratory Viral Infections in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Overview
Publisher Dove Medical Press
Specialty Pulmonary Medicine
Date 2021 May 17
PMID 33994783
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD) that require hospitalization and emergency department visits are associated with considerable morbidity and mortality. Respiratory viral infection is an important cause of severe AECOPD. We evaluated the incidence and prognostic factors of viral infection in severe AECOPD.

Patients And Methods: We performed a retrospective study of 262 cases of severe AECOPD in 192 patients who required hospitalization and emergency department visits at a tertiary teaching hospital in Daegu, Korea. A multiplex polymerase chain reaction panel using a nasopharyngeal swab sample was performed to detect viral infection.

Results: Viral infection was detected in 108 events (41.2%) from 96 patients. The most common virus was rhinovirus/enterovirus (27.5%), followed by influenza virus (22.5%), respiratory syncytial virus (13.3%), parainfluenza virus (12.5%), coronavirus (12.5%), metapneumovirus (7.5%), and adenovirus (4.2%). Virus-positive exacerbations, compared to virus-negative exacerbations, had a higher frequency of symptoms of rhinopharyngitis, higher neutrophil count and C-reactive protein (CRP) level, and lower eosinophil count. Multivariate analysis demonstrated that elevated CRP levels (odds ratio [OR], 2.76; 95% confidence interval [CI], 1.24-6.15), symptoms of rhinopharyngitis (OR, 1.98; 95% CI, 1.03-3.78), low eosinophil count (OR, 1.74; 95% CI, 1.03-2.92), and inhaled corticosteroid (ICS) use (OR, 1.70; 95% CI 1.04-2.80) were associated with viral infection in severe AECOPD.

Conclusion: The incidence of viral infection in severe AECOPD was 41.2%, and the most commonly detected virus was rhinovirus/enterovirus. Increased CRP level, symptoms of rhinopharyngitis, low eosinophil count, and use of ICS were associated with viral infection in severe AECOPD.

Citing Articles

Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies.

Di Chiara C, Sartori G, Fantin A, Castaldo N, Crisafulli E Medicina (Kaunas). 2025; 61(1).

PMID: 39859079 PMC: 11766895. DOI: 10.3390/medicina61010097.


Advances on the Role of Lung Macrophages in the Pathogenesis of Chronic Obstructive Pulmonary Disease in the Era of Single-Cell Genomics.

Li X, Zhang H, Chi X, Ruan W, Meng X, Deng J Int J Med Sci. 2025; 22(2):298-308.

PMID: 39781522 PMC: 11704685. DOI: 10.7150/ijms.100160.


Efficacy of Prophylactic Antibiotics in COPD: A Systematic Review.

Tran A, Ghanem A, More M, Nagy A, Toth A Antibiotics (Basel). 2025; 13(12.

PMID: 39766500 PMC: 11672715. DOI: 10.3390/antibiotics13121110.


Comparison of Infection Risks Between Various Inhaled and Intranasal Corticosteroids: A Pharmacovigilance Analysis Based on the FAERS Database.

Lan Y, Hu D, Huang S, Ma Q, Chen L, Xu M Int J Chron Obstruct Pulmon Dis. 2024; 19:1457-1469.

PMID: 38948909 PMC: 11214551. DOI: 10.2147/COPD.S466588.


Association between serum phosphate and in-hospital mortality of patients with AECOPD: A retrospective analysis on eICU database.

Li S, Huang Q, Nan W, He B Heliyon. 2023; 9(9):e19748.

PMID: 37809538 PMC: 10559067. DOI: 10.1016/j.heliyon.2023.e19748.


References
1.
Rohde G, Wiethege A, Borg I, Kauth M, Bauer T, Gillissen A . Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003; 58(1):37-42. PMC: 1746460. DOI: 10.1136/thorax.58.1.37. View

2.
Hamelin M, Cote S, LaForge J, Lampron N, Bourbeau J, Weiss K . Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease. Clin Infect Dis. 2005; 41(4):498-502. DOI: 10.1086/431981. View

3.
Alqahtani J, Njoku C, Bereznicki B, Wimmer B, Peterson G, Kinsman L . Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis. Eur Respir Rev. 2020; 29(156). PMC: 9488450. DOI: 10.1183/16000617.0166-2019. View

4.
Boixeda R, Rabella N, Sauca G, Delgado M, Martinez-Costa X, Mauri M . Microbiological study of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and the usefulness of analytical and clinical parameters in its identification (VIRAE study). Int J Chron Obstruct Pulmon Dis. 2012; 7:327-35. PMC: 3379868. DOI: 10.2147/COPD.S30568. View

5.
Biancardi E, Fennell M, Rawlinson W, Thomas P . Viruses are frequently present as the infecting agent in acute exacerbations of chronic obstructive pulmonary disease in patients presenting to hospital. Intern Med J. 2016; 46(10):1160-1165. PMC: 7165870. DOI: 10.1111/imj.13213. View